Bacteremic Pneumonia in Neutropenic Patients With Cancer

Open Access
Publisher Website
Google Scholar
Abstract
DESPITE advances in antibiotic therapy, pneumonia remains a major cause of morbidity and mortality.1-3 In recent years, a change in the patient population with pneumonia, which includes an increasing number of patients immunosuppressed by human immunodeficiency virus infection, transplantation, immunosuppressive drugs, and cancer, has been noted.4 However, investigators have excluded such patients from most prospective studies, and the American Thoracic Society has provided guidelines that exclude immunosuppressed patients.5,6 Therefore, there is a need for studies dealing with pneumonia in the different groups of immunosuppressed patients.